查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1820122

腸溶軟膠囊市場報告（按類型、應用、配銷通路和地區）2025-2033

Enteric Softgel Capsules Market Report by Type, Application, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球腸溶軟膠囊市場規模達27億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到37億美元，2025-2033年期間的複合年成長率（CAGR）為3.6%。市場成長主要受全球老年人口成長、慢性疾病和營養缺乏症盛行率上升以及營養和膳食補充劑日益普及的驅動。

腸溶軟膠囊市場趨勢：

慢性病盛行率不斷上升

糖尿病、心血管疾病和胃腸道疾病等慢性疾病的盛行率不斷上升，大大推動了腸溶軟膠囊市場的成長。根據美國疾病管制與預防中心的數據，美國約有1.29億人患有至少一種主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血壓。此外，美國十大主要死因中有五種是或與可預防和可治療的慢性疾病密切相關。此外，在過去二十年中，慢性疾病的盛行率穩步上升，預計這一趨勢還將持續。腸溶軟膠囊能夠持續標靶釋放藥物，這對於治療通常需要長期治療的疾病非常有益。透過在腸道而不是胃部釋放藥物，這些膠囊可以確保藥物在最佳作用區域被吸收。這種標靶給藥是治療慢性疾病的理想選擇，因為它可以增強療效並減少副作用。隨著人口老化、久坐不動的生活方式以及飲食習慣的改變導致全球慢性病負擔加重，腸溶軟膠囊和其他複雜的藥物輸送技術的需求可能會越來越大。

對營養補充品的偏好日益增加

推動腸溶軟膠囊市場收入成長的另一個因素是消費者對膳食補充劑日益成長的興趣。根據美國國家醫學圖書館的數據，全球營養保健品和補充劑市場在過去十年中穩步成長，據報導2019年的價值為3530億美元。該領域的研究也在成長，PubMed上已發表的與營養保健品或膳食補充劑相關的文章超過70,000篇。此外，由嚴重急性呼吸道症候群冠狀病毒2（SARS-CoV-2）引起的冠狀病毒病（COVID-19）大流行始於2019年11月，導致膳食補充劑和營養保健品的銷量在2020年初進一步成長。營養保健品產業廣泛使用腸溶軟膠囊來提供維生素、礦物質和其他營養補充品。這些膠囊具有許多好處，包括增加營養吸收和生物利用度，保護脆弱成分免受胃酸侵蝕，並提高客戶便利性和依從性。隨著人們越來越意識到營養補充品的健康益處，越來越多的人將營養補充品納入日常生活。這一趨勢在老年人群體和注重健康的消費者中尤其明顯，他們希望透過補充劑來預防或治療疾病。

老年人口不斷增加

不斷成長的老年人口是腸溶軟膠囊市場價值成長的另一個主要因素。根據聯合國 (UN) 統計，全球 65 歲及以上人口預計將成長一倍以上，從 2021 年的 7.61 億增加到 2050 年的 16 億。 80 歲及以上人口的成長速度甚至更快。老年人通常有特殊的醫療保健需求，例如管理多種慢性疾病，需要易於吞嚥、對胃腸道友善的藥物。腸溶軟膠囊可以滿足這些需求，它提供了一種實用且高效的處方藥和膳食補充劑的遞送方法。由於老年族群中消化問題較常見，這些膠囊的腸溶衣尤其有用。此外，隨著預期壽命的延長和出生率的下降，世界老年人口正在不斷擴大。腸溶軟膠囊可提高服藥依從性和治療效果，預計隨著人口結構轉變，這類醫療保健產品的需求將會增加。

腸溶軟膠囊市場區隔：

按類型分列：

  • 明膠膠囊
  • 非明膠軟膠囊

明膠膠囊佔大部分市場佔有率

根據腸溶膠囊市場預測，明膠膠囊因其卓越的生物相容性和吸收性而廣受歡迎。明膠源自動物膠原蛋白，是一種易於人體吸收和消化的天然蛋白質。由於其生物相容性，它對各種消費者（包括胃敏感或飲食受限的消費者）來說都是安全的。明膠膠囊也因其高生物利用度（即活性物質能夠被血液有效吸收）而聞名。因此，用於製造軟膠囊的明膠需求不斷成長。根據美國國家醫學圖書館的數據，2020 年明膠市場規模達到 31.8 億美元，並且預計到 2024 年將達到 40.8 億美元，正如同一報告所預測的那樣。

按應用分類：

  • 健康補充品
  • 製藥

保健品佔業界最大佔有率

保健品市場佔據主導地位，這主要是因為人們越來越意識到維護整體健康和福祉的重要性。根據Research Gate的數據，53.7%的受訪者根據醫生的建議服用膳食補充劑，28.5%的受訪者自行決定服用，15.9%的受訪者聽從朋友的建議服用；87.4%的受訪者在藥店購買補充劑。隨著健康產業的發展，越來越多的人積極關注自身健康，並尋求有助於增強免疫力、提供重要營養素和預防慢性疾病的補充劑。腸溶軟膠囊可以保護脆弱成分免受胃酸侵蝕，提高腸道吸收率和生物利用度，因此是這些營養素的理想輸送方式。

按配銷通路細分：

  • 超市和大賣場
  • 藥局和藥局
  • 網路商店

藥房和藥局是主要的細分市場

藥房和藥局在市場中佔有相當大的佔有率。這些分佈廣泛且消費者友好的零售點為處方藥和營養補充劑提供了實用的銷售點。藥劑師可以提供專業指導，顧客經常選擇從藥局購買健康相關產品，從而確保他們的決定是明智的。根據麥肯錫發布的報告，零售連鎖店是四種藥局類型中規模最大、最普遍的，佔2021年門市總數的三分之一，約佔處方收入的三分之一。以每家店計算，零售連鎖店每年配發約138,000張處方，比雜貨店多出約50%，雜貨店是美國零售點數量第二多的處方藥配藥商。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據最大的腸溶軟膠囊市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是腸溶軟膠囊最大的區域市場。

北美腸溶軟膠囊市場前景看好的一個重要促進因素是慢性病盛行率的上升。根據美國國家醫學圖書館的數據，美國50歲及以上人口數量將從2020年的1.3725億增加61.11%，到2050年將達到2.2113億。在50歲及以上人口中，患有至少一種慢性病的人數預計將從2020年的7,152.2萬人增加99.5%，到2050年將達到1.4266億。主要由於人口老化和生活方式的選擇，糖尿病、心血管疾病和胃腸道疾病等疾病在該地區普遍存在。腸溶軟膠囊可針對緩釋藥物，這對通常需要長期治療的慢性病患者非常有益。這些膠囊是管理慢性病的建議選擇，因為它們可以增強治療效果並最大限度地減少副作用。北美巨大的市場佔有率主要歸因於慢性病盛行率的上升，這反過來又推動了對高效實用的藥物輸送方法的需求。

（請注意，這只是關鍵參與者的部分名單，完整名單將在報告中提供。）

  • 根據腸溶軟膠囊市場研究報告，主要參與者正在建立策略聯盟和合作夥伴關係，以鞏固其地位。他們也透過與學術機構、研究中心和其他製藥公司合作進行創新。這些合作夥伴關係通常促成技術和資訊的交流以及新產品的共同開發，所有這些都極大地增強了企業的競爭優勢。提高產能是腸溶軟膠囊產業主要競爭對手使用的另一個重要策略。企業可以透過投資新的生產設施或改造現有的生產設施來提高產能和營運效率。此外，企業正在進入新興市場，這些市場對先進醫藥產品的需求正在不斷成長，這提供了巨大的成長機會。

本報告回答的關鍵問題

  • 2024年全球腸溶軟膠囊市場規模是多少
  • 2025-2033年全球腸溶軟膠囊市場的預期成長率是多少
  • COVID-19 對全球腸溶軟膠囊市場有何影響
  • 推動全球腸溶軟膠囊市場的關鍵因素有哪些
  • 全球腸溶軟膠囊市場按類型分類如何？
  • 根據應用，全球腸溶軟膠囊市場如何分佈
  • 根據配銷通路，全球腸溶軟膠囊市場如何分佈
  • 全球腸溶軟膠囊市場的主要區域有哪些
  • 全球腸溶軟膠囊市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 2024年全球腸溶軟膠囊市場規模？ 2025-2033年全球腸溶軟膠囊市場的預期成長率為何？
  • COVID-19 對全球腸溶軟膠囊市場有何影響？
  • 推動全球腸溶軟膠囊市場發展的關鍵因素有哪些？
  • 全球腸溶軟膠囊市場按類型分為哪些類型？
  • 根據應用，全球腸溶軟膠囊市場是如何分佈的？
  • 根據配銷通路，全球腸溶軟膠囊市場如何分佈？
  • 全球腸溶軟膠囊市場的主要區域有哪些？
  • 全球腸溶軟膠囊市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球腸溶軟膠囊市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 明膠膠囊
  • 非明膠軟膠囊

第7章：市場區隔：依應用

  • 健康補充品
  • 製藥

第8章：市場區隔：按配銷通路

  • 超市和大賣場
  • 藥局和藥局
  • 網路商店

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Aenova Group GmbH
    • BASF SE
    • Catalent, Inc.
    • Colorcon Inc.
    • Fuji Capsule Co., Ltd.
    • Lonza Group AG
    • Now Health Group, Inc.
    • ProCaps Group
    • Super Spectrim
    • Thermo Fisher Scientific, Inc.
Product Code: SR112025A4232

The global enteric softgel capsules market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.6% during 2025-2033. The market is primarily driven by the growing global geriatric population, the rising prevalence of chronic medical disorders and nutrient-deficient diseases, and the growing acceptance of nutritional and dietary supplements.

Enteric Softgel Capsules Market Trends:

Growing prevalence of chronic diseases

The enteric softgel capsule market growth is significantly driven by the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and gastrointestinal disorders. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Moreover, over the past two decades prevalence has increased steadily, and this trend is expected to continue. Enteric softgel capsules offer a continuous and targeted release of medication, which is beneficial for treating illnesses that often require long-term treatment. By releasing its contents in the intestines instead of the stomach, these capsules make sure the medication is absorbed where it works best. This targeted administration is a desirable alternative for managing chronic diseases since it can enhance therapeutic outcomes and lessen side effects. With aging populations, sedentary lifestyles, and changing dietary habits contributing to the global burden of chronic diseases, enteric softgel capsules and other sophisticated drug delivery technologies are likely to become more and more in demand.

Increasing preference toward nutritional supplements

Another factor propelling the enteric softgel capsule market revenue is the growing inclination of consumers toward dietary supplements. As per the National Library of Medicine, the global nutraceuticals and supplements market has steadily grown over the past decade and was reported to be worth $353 Billion in 2019. Research in the field has also grown, with over 70,000 published articles available in PubMed relating to nutraceuticals or dietary supplements respectively. Besides, the occurrence of the coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) starting in November 2019 led to an even greater increase in sales of dietary supplements and nutraceuticals in early 2020. The nutraceutical sector uses enteric softgel capsules extensively to provide vitamins, minerals, and other nutritional supplements. These capsules have a number of benefits, including as increased nutrient absorption and bioavailability, shielding delicate components from stomach acids, and improving customer convenience and compliance. More people are including nutritional supplements in their regular routines as awareness of their health advantages develops. This trend is especially prominent among older populations and health-conscious consumers who want to use supplements to prevent or treat medical issues.

Rising geriatric population

Another major aspect increasing the enteric softgel capsule market value is the growing geriatric population. According to the United Nations (UN), the global population aged 65 years or older is expected to be more than double, increasing from 761 million in 2021 to 1.6 billion by 2050. The population aged 80 years or older is growing at an even faster rate. Elderly people frequently have particular healthcare demands, such as managing several chronic illnesses and requiring easy-to-swallow, gastrointestinal-friendly drugs. These criteria are met by enteric softgel capsules, which provide a practical and efficient method of delivering prescription drugs and dietary supplements. These capsules' enteric coating is especially helpful as digestive problems are more common in the elderly population. Additionally, as life expectancy rises and birth rates fall, the world's senior population is expanding. Enteric softgel capsules, which can improve medication adherence and treatment outcomes, are among the healthcare items that are predicted to see an increase in demand as a result of this demographic transition.

Enteric Softgel Capsules Market Segmentation:

Breakup by Type:

  • Gelatin Capsules
  • Non-Gelatin Softgel Capsules

Gelatin capsules accounts for the majority of the market share

As per enteric capsules market forecast, gelatin capsules are widely preferred due to their exceptional biocompatibility and absorption. Derived from animal collagen, gelatin is an easily absorbed and digested natural protein by the human body. It is also safe for a variety of consumers including those with sensitive stomachs or dietary restrictions due to its biocompatibility. Gelatin capsules are also renowned for having a high bioavailability, or the ability of the active substances to be effectively absorbed into the bloodstream. Hence, there is an escalating demand for gelatin for manufacturing softgel capsules. As per National Liabrary of Medicine, the market for gelatin in 2020 reached USD 3.18 Billion and is further expected to reach USD 4.08 Billion by 2024 as forecasted in the same report.

Breakup by Application:

  • Health Supplements
  • Pharmaceuticals

Health supplements hold the largest share of the industry

The market is dominated by health supplements primarily due to the increasing awareness of the value of preserving general health and wellbeing. According to the Research Gate, 53.7 % of the participants of the survey took dietary supplements upon the doctor's advice, 28.5 % took them with their own decision, and 15.9 % took them after friend advice; 87.4 % of the participants bought supplements in the pharmacy. As the wellness sector grows, more people are taking an active role in their health and looking for supplements that help boost immunity, deliver vital nutrients, and stave against chronic illnesses. As enteric softgel capsules can shield delicate components from stomach acids, improving absorption and bioavailability in the intestines, they are an appealing delivery option for these nutrients.

Breakup by Distribution Channel:

  • Supermarkets and Hypermarkets
  • Pharmacy and Drug Stores
  • Online Stores

Pharmacy and drug stores represent the leading market segment

Pharmacy and drug stores hold a significant market share in the market. These widely dispersed and consumer-friendly retail locations offer a practical point of sale for prescription drugs and nutritional supplements. Pharmacists can offer expert guidance, customers frequently choose to purchase health-related products from pharmacies, guaranteeing that their decisions are well-informed. As per the report published by Mckinsey, retail chains are the largest and most prevalent of the four pharmacy types, representing a third of stores and about a third of prescription revenues in 2021. On a per-store basis, retail chains dispense approximately 138,000 prescriptions annually about 50 percent more than grocers, the next largest prescription dispensers per retail location in US.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest enteric softgel capsules market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for enteric softgel capsules.

An important driver creating a favorable enteric softgel capsules market outlook in North America is the increasing prevalence of chronic disorders. As per National Library of Medicine, the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050.Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Owing mostly to aging populations and lifestyle choices, conditions like diabetes, cardiovascular illnesses, and gastrointestinal ailments are prevalent in the area. Enteric softgel capsules provide targeted and sustained release of medications, which is beneficial for patients with chronic conditions who often need long-term treatment. These capsules are a recommended option for managing chronic diseases since they enhance therapeutic outcomes and minimize adverse effects. The substantial market share of North America is mostly attributed to the rising prevalence of chronic illnesses, which in turn drives demand for efficient and practical drug delivery methods.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major enteric softgel capsules companies in the industry include Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • As per enteric softgel capsules market research report, key players are establishing strategic alliances and partnerships to strengthen their position. They are also innovating through collaboration with academic institutions, research centers, and other pharmaceutical firms. These partnerships frequently result in the exchange of technology and information as well as the co-development of new goods, all of which greatly strengthen a business's competitive advantage. Increasing production capacity is yet another important tactic used by top competitors in the enteric softgel capsule industry. Businesses can boost production capacity and boost operational efficiency by investing in new production facilities or renovating existing ones. Moreover, companies are entering emerging markets, where the demand for advanced pharmaceutical products is rising, which is providing significant growth opportunities.

Key Questions Answered in This Report

  • 1.What was the size of the global enteric softgel capsules market in 2024?
  • 2.What is the expected growth rate of the global enteric softgel capsules market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global enteric softgel capsules market?
  • 4.What are the key factors driving the global enteric softgel capsules market?
  • 5.What is the breakup of the global enteric softgel capsules market based on the type?
  • 6.What is the breakup of the global enteric softgel capsules market based on the application?
  • 7.What is the breakup of the global enteric softgel capsules market based on the distribution channel?
  • 8.What are the key regions in the global enteric softgel capsules market?
  • 9.Who are the key players/companies in the global enteric softgel capsules market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Softgel Capsules Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gelatin Capsules
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Gelatin Softgel Capsules
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Health Supplements
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmaceuticals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Supermarkets and Hypermarkets
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacy and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aenova Group GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BASF SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Catalent, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Colorcon Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Fuji Capsule Co., Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Lonza Group AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Now Health Group, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 ProCaps Group
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Super Spectrim
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific, Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Enteric Softgel Capsules Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Softgel Capsules Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Enteric Softgel Capsules Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Enteric Softgel Capsules Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Enteric Softgel Capsules Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Enteric Softgel Capsules Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Enteric Softgel Capsules Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Enteric Softgel Capsules (Gelatin Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Enteric Softgel Capsules (Gelatin Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Enteric Softgel Capsules (Health Supplements) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Enteric Softgel Capsules (Health Supplements) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Enteric Softgel Capsules (Pharmaceuticals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Enteric Softgel Capsules (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Enteric Softgel Capsules (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Enteric Softgel Capsules (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: Enteric Softgel Capsules Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Enteric Softgel Capsules Industry: SWOT Analysis
  • Figure 72: Global: Enteric Softgel Capsules Industry: Value Chain Analysis
  • Figure 73: Global: Enteric Softgel Capsules Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Softgel Capsules Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Enteric Softgel Capsules Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Enteric Softgel Capsules Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Enteric Softgel Capsules Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Enteric Softgel Capsules Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Enteric Softgel Capsules Market: Competitive Structure
  • Table 7: Global: Enteric Softgel Capsules Market: Key Players